Winning Health Technology Group Co., Ltd. (SHE: 300253)

Winning Health Technology Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Operating Revenue	3,173	3,161	3,091	2,749	2,264	1,892
Other Revenue	2.47	2.47	1.38	0.94	2.23	15.62
Revenue	3,176	3,163	3,093	2,750	2,267	1,908
Revenue Growth (YoY)	1.69%	2.28%	12.46%	21.34%	18.79%	32.61%
Cost of Revenue	1,768	1,740	1,742	1,476	1,041	926.86
Gross Profit	1,407	1,424	1,351	1,275	1,226	981.15
Selling, General & Admin	569.44	654.9	707.67	585.95	464.12	381.9
Research & Development	319.89	333.3	313.77	255.67	229.45	205.63
Other Operating Expenses	31.92	29.65	25.8	-79.54	-80.1	-79.94
Operating Expenses	1,077	1,157	1,282	995.35	748.5	589.86
Operating Income	330.59	266.36	69.54	279.34	477.18	391.29
Interest Expense	-66.9	-64.05	-59.63	-46.68	-9.88	-8.82
Interest & Investment Income	21.88	43.09	20.62	11.8	105.82	6.34
Currency Exchange Gain (Loss)	-0.01	-0.01	-	0	-0.02	-
Other Non Operating Income (Expenses)	1.2	0.78	-14.25	-22.38	-10.3	-9.96
EBT Excluding Unusual Items	286.75	246.17	16.28	222.08	562.81	378.85
Impairment of Goodwill	-6.6	-6.6	-22.94	-	-	-
Gain (Loss) on Sale of Investments	-74.78	-50.46	-90.56	116.51	-34.69	-7.16
Gain (Loss) on Sale of Assets	-0.28	-0.43	-0.52	0.18	0.23	-0.09
Asset Writedown	36.91	-0.05	-0.31	-0.31	-0.69	-0.14
Legal Settlements	-0.26	-0.26	-	-	-	-
Other Unusual Items	152.39	152.39	136.6	34.72	18.5	41.16
Pretax Income	394.12	340.75	38.54	373.17	546.16	412.63
Income Tax Expense	49.84	23.13	23.78	19.43	40.63	17.05
Earnings From Continuing Operations	344.28	317.62	14.76	353.73	505.53	395.57
Minority Interest in Earnings	15.97	40.34	93.88	24.44	-14.43	2.85
Net Income	360.25	357.96	108.64	378.17	491.1	398.42
Net Income to Common	360.25	357.96	108.64	378.17	491.1	398.42
Net Income Growth	197.87%	229.49%	-71.27%	-22.99%	23.26%	31.36%
Shares Outstanding (Basic)	2,156	2,147	2,139	2,143	2,125	2,102
Shares Outstanding (Diluted)	2,180	2,195	2,143	2,147	2,138	2,114
Shares Change (YoY)	0.28%	2.42%	-0.22%	0.44%	1.15%	-0.07%
EPS (Basic)	0.17	0.17	0.05	0.18	0.23	0.19
EPS (Diluted)	0.17	0.16	0.05	0.18	0.23	0.19
EPS Growth	197.03%	221.70%	-71.21%	-23.33%	21.86%	31.45%
Free Cash Flow	38.55	-128.53	-223.26	81.83	203.36	41.56
Free Cash Flow Per Share	0.02	-0.06	-0.10	0.04	0.10	0.02
Dividend Per Share	0.020	0.020	0.010	0.020	0.025	0.019
Dividend Growth	100.00%	100.00%	-50.00%	-20.00%	30.21%	24.68%
Gross Margin	44.32%	45.00%	43.69%	46.35%	54.08%	51.42%
Operating Margin	10.41%	8.42%	2.25%	10.16%	21.05%	20.51%
Profit Margin	11.34%	11.32%	3.51%	13.75%	21.67%	20.88%
Free Cash Flow Margin	1.21%	-4.06%	-7.22%	2.98%	8.97%	2.18%
EBITDA	352.67	288.13	90.9	299.2	495.7	409.03
EBITDA Margin	11.11%	9.11%	2.94%	10.88%	21.87%	21.44%
D&A For EBITDA	22.08	21.77	21.35	19.86	18.52	17.74
EBIT	330.59	266.36	69.54	279.34	477.18	391.29
EBIT Margin	10.41%	8.42%	2.25%	10.16%	21.05%	20.51%
Effective Tax Rate	12.64%	6.79%	61.71%	5.21%	7.44%	4.13%
Revenue as Reported	3,176	3,163	3,093	2,750	2,267	1,908

Source: S&P Capital IQ. Standard template. Financial Sources.